#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Efficacy of intravenous prasinezumab versus placebo in Parkinson’s disease patients with severe GBA mutation: a 104‑week randomized double‑blind study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Luxembourg Spain Sweden

  • Cognitive effects of a three‑month methylphenidate course in Parkinson’s disease patients with mild cognitive impairment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Safety, CNS penetration and target engagement of Mirivadelgat in participants with Parkinson’s disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    Norway

  • A study to optimize the delivery of AAV2-GDNF and gadoteridol into the brain for patients with Parkinson’s disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Long-term safety and effectiveness follow-up study of AB-1005 gene therapy in patients with Parkinson’s disease or multiple system atrophy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • A study to test if BHV-8000 is effective and safe for adults with early Parkinson’s disease

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia France Germany Italy +4

  • Study of safinamide compared to placebo for pain relief in patients with Parkinson’s disease who experience motor fluctuations

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study of serotonin system changes in early Parkinson’s disease using [11C]DASB and [11C]SB207145 PET imaging in people with SNCA gene mutations

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Safety and Effects of LY3884961 for Patients with Parkinson’s Disease and a GBA1 Mutation

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands